N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

about

Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study.

P2860

Q37165169-B7ED81C3-34CA-4A68-8505-DBA864523979

P2860

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

Item

http://www.wikidata.org/entity/Q36106828

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@ast

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@en

type

Item

label

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@ast

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@en

prefLabel

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@ast

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@en

P1476

N-Farnesyloxy-norcantharimide ...... and interleukin-2 production.

@en

P2093

Cheng-Deng Kuo

http://www.w3.org/2001/XMLSchema#string

Hui-Fen Liao

http://www.w3.org/2001/XMLSchema#string

Jin-Yi Wu

http://www.w3.org/2001/XMLSchema#string

Ming-Che Chang

http://www.w3.org/2001/XMLSchema#string

Yu-Jen Chen

http://www.w3.org/2001/XMLSchema#string

P2860

From receptors to stress-activated MAP kinases

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma

MAPKs: new JNK expands the group

Organization and regulation of mitogen-activated protein kinase signaling pathways.

Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro.

New insights into the control of MAP kinase pathways.

IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.

MAP kinases in the immune response.

P304

1034-1042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CAD.0000000000000284

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26288134

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

4588604

http://www.w3.org/2001/XMLSchema#string

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

about

P2860

P2860

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932